Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation of human antibodies for treating TNF-α associated disorders

Formulation of human antibodies for treating TNF-α associated disorders

US Patent 8216583 · Granted Jul 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation of human antibodies for treating TNF-alpha associated disorders2018
Formulation of human antibodies for treating TNF-alpha associated disorders2018
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2016
Formulation of human antibodies for treating TNF-alpha associated disorders2016
Formulation of human antibodies for treating TNF-α associated disorders2016
Formulation of human antibodies for treating TNF-α associated disorders2016